ArticleTherapeutic advances in psychopharmacology2021

Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression.

Adam Włodarczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.